$68.98
-3.77-5.19%
Last update: Nov 6, 4:40 AM
TransMedics Group Inc
TMDXNASDAQ
The average analyst price target for TransMedics Group is $112.79, 46.5% above the current price. Of 13 analysts, 10 rate it Buy and 3 Hold. Targets range from $70 to $178. The latest change came on Oct 13, 2026, when Canaccord Genuity lowered its price target on TransMedics Group from $95 to $94 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
